Medicis ships Restylane, Perlane after FDA nod
Mar 10, 2010
By: Bill Gillette
"Scottsdale, Ariz. — Medicis, based here, has begun shipment of the dermal fillers Restylane-L and Perlane-L (both hyaluronic acid/lidocaine), GlobeNewswire reports.
The Food and Drug Administration (FDA) on Jan. 29 approved Restylane-L for implantation into the mid- to deep dermis and Perlane-L for implantation into the deep dermis to superficial subcutis. Both fillers are intended for the correction of moderate to severe facial wrinkles, such as nasolabial folds"